Jorie to Reveal the Most Advanced Automation Ever Seen in Revenue Management at HLTH 2025

September 16, 2025 4:03 PM

Jorie AI, a leader in healthcare automation, will unveil a newly trademarked advanced automation at HLTH 2025 in Las Vegas (October 19-22), giving attendees the first-ever look at its name, logo, and groundbreaking capabilities.This exclusive launch, taking place at Booth #2413 in a premier location at the entrance of the show floor, will showcase some of the most advanced automation ever introduced to revenue cycle management-demonstrating how...

Read more

MEDITECH Expanse 2025 Top-Ranked EHR for Community Hospitals, User Survey Highlights Opportunities for Growth

September 16, 2025 4:00 PM

Black Book Research announced that MEDITECH Expanse had been ranked the #1 electronic health record (EHR) platform for community hospitals under 150 beds earlier this year. In Q3 surveys of 128 verified MEDITECH hospital clients, the platform scored highest for vendor reliability, implementation support, and client retention, with especially strong loyalty among corporate health systems and regional chains.Black Book's independent survey also...

Read more

TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers

September 16, 2025 2:00 PM

TruMerit, a global leader in healthcare workforce development, today launched two new global credentials for healthcare workers specializing in rehabilitation, habilitation, and restorative care.The Certified Global Health Worker-Rehabilitation (CGHW-R) and the Certified Global Health Worker-Rehabilitation Advanced (CGHW-RA) have been developed specifically for eligible health workers worldwide who wish to have their applied experience and...

Read more

Medicare Cuts & Tech Gaps Drive Home Health Nurse Exodus

September 16, 2025 10:45 AM

Black Book Research today released 2025 survey findings from U.S. home health executives, finance leaders, and clinical directors showing that technology inefficiencies are a primary driver of nurse attrition. Respondents also warn that proposed Medicare home health payment reductions totaling 6.4% over 2026-2027 will intensify workforce pressure unless agencies can invest in modern IT.Home health is absorbing rising acuity while competing for...

Read more

Mass General Brigham and Recora Announce Collaboration on Cardiac Program

September 16, 2025 10:00 AM

Mass General Brigham (MGB) and Recora today announced a collaboration to broaden access to the Benson-Henry Institute for Mind Body Medicine (BHI) Intensive Cardiac Rehabilitation (ICR) program. This program is one of only three intensive cardiac rehabilitation models nationally approved by Medicare. It is distinguished by its integration of evidence-based stress management, mind-body medicine, nutritional guidance, supervised exercise, and...

Read more

Christopher G Chute, MD, DrPH, FACMI, to Be Awarded Morris F. Collen Award of Excellence at the AMIA 2025 Annual Symposium

September 16, 2025 9:42 AM

The American College of Medical Informatics (ACMI) will present the 2025 Morris F. Collen Award of Excellence to Christopher G Chute, MD, DrPH, FACMI, on November 16 during the opening session of the AMIA 2025 Annual Symposium, November 15-19 in Atlanta.In honor of Morris F. Collen, a thought leader in the field of medical informatics, the prestigious award is presented to an individual whose personal commitment and dedication to medical...

Read more

NCQA Unveils 2025 Health Plan Ratings

September 16, 2025 9:05 AM

The National Committee for Quality Assurance (NCQA) today announced its 2025 Health Plan Ratings-an annual report that helps health care consumers and regulators assess the quality and effectiveness of health plans. Ratings evaluate commercial, Medicare Advantage and Medicaid health plans based on measures of clinical quality and patient experience. 2025 Health Plan Ratings are primarily based on 2024 performance data, with some Medicare...

Read more

High BMI FTM Top Surgery Without Limits: Dr. Javad Sajan Offers Inclusive, Life-Saving Gender-Affirming Top Surgery

September 16, 2025 9:00 AM

Dr. Javad Sajan of Allure Esthetic Plastic Surgery, a renowned plastic surgeon and one of the nation's leading FTM top surgery specialists, announces that his practice is offering high BMI gender-affirming top surgery with no BMI limits across the United States. This inclusive approach allows transgender and non-binary patients - even those with BMIs over 50 - to undergo medically necessary FTM chest reconstruction without being turned away due...

Read more

As Fall Sports Season Begins, ZetrOZ Systems' SAM Technology Helps Athletes Prevent Re-Injury

September 16, 2025 9:00 AM

Fall sports are back, and athletes and their trainers are using ZetrOZ Systems' sustained acoustic medicine (sam®) technology to treat injuries and help players recover and stay game-ready throughout the demanding fall season.Sustained acoustic medicine, invented by ZetrOZ Systems, is continuous, long-duration ultrasound treatment applied directly to the site of an injury. The ZetrOZ Systems sam® X1 and 2.0 devices are the only wearable...

Read more

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

September 16, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, announced today a strategic initiative to rapidly increase the production capacity of its BUZZ BOMB™ single dose caffeine pre-workout supplement through a new manufacturing relationship with SupraNaturals, a well-established contract manufacturer of nutritional and dietary supplements. As part of...

Read more

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

September 16, 2025 8:30 AM

Aptevo Therapeutics ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology company developing novel bispecific and trispecific immuno-oncology therapeutics, today announced a 100% remission rate in Cohort 3 of its Phase 1b/2 RAINIER trial evaluating mipletamig, the Company's first-in-class CD123 x CD3 bispecific antibody, in combination with venetoclax + azacitidine for newly diagnosed patients with acute myeloid leukemia...

Read more

Avel eCare Honors Telehealth Awareness Week with Theme "Powered by People"

September 16, 2025 8:07 AM

Avel eCare is proud to join healthcare organizations nationwide in celebrating Telehealth Awareness Week, September 14-20, 2025. This year, Avel is honoring the week with a unique theme: Powered by People."For more than 30 years, our success has been driven by the people behind the care," said Doug Duskin, CEO of Avel eCare. "Behind every call, every computer screen, and every virtual consult stands a team of dedicated individuals. From...

Read more

Allied OMS Expands into Greater Austin through Partnership with Heart of Texas Oral Surgery

September 16, 2025 8:00 AM

Allied OMS, the nation's leading doctor-owned and doctor-led management services organization (MSO) for oral and maxillofacial surgeons, today announced its entry into the Greater Austin market through a partnership with Heart of Texas Oral Surgery.Led by Dr. Jeff Alford, Heart of Texas Oral Surgery provides the full scope of oral and maxillofacial surgery services, including wisdom tooth removal, dental extractions, dental implants, corrective...

Read more

MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals

September 16, 2025 7:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced positive results demonstrating that its oral drug candidate Ketamir-2 restored normalized behavior in stressed animals within a validated model of post-traumatic stress disorder (PTSD). Ketamir-2 is currently being evaluated in an...

Read more

CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025

September 16, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), the parent company of The CBD Vault, is proud to announce significant progress following its recent participation at the NECANN New Jersey 2025 Cannabis Conference, one of the largest cannabis trade shows in the country. This high-visibility event has positioned CBDL at the forefront of the industry, paving the way for Letters of Intent (LOIs) and advanced negotiations with five major dispensaries across...

Read more

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans

September 16, 2025 6:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The data from an ongoing Phase 4 clinical trial evaluating the safety, tolerability and immunogenicity of the 2025-2026 formula of Spikevax showed, on average, greater than an 8-fold increase in neutralizing antibodies against the LP.8.1 variant in...

Read more

Mentavi Health CEO to Spotlight Trust and Validation at Tech Week Grand Rapids 2025

September 15, 2025 5:50 PM

Mentavi Health will take a prominent role in Tech Week Grand Rapids (September 15-19, 2025), where CEO and Tech Week co-chair Keith Brophy will share insights at the intersection of health care and technology, drawing on Mentavi's peer-reviewed, clinically validated digital diagnostic solutions as an example of how innovation can set new standards for trust in digital health.Mentavi Health, founded in 2018, provides a broad spectrum of online...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025

September 15, 2025 5:30 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2025 were approximately $2.0 million and $6.9, million, respectively. Revenues for the...

Read more

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

September 15, 2025 4:50 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2026, ended July 31, 2025.First Quarter and Recent Highlights:Total revenue of $14 millionAdjusted EBITDA of $60,000Appointment of Rob Brainin as Chief Executive Officer to lead the next phase of growthRob Brainin, newly appointed CEO of Champions, commented, "It is great to be...

Read more

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

September 15, 2025 3:55 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2026, ended July 31, 2025.First Quarter and Recent Highlights:Total revenue of $14 millionAdjusted EBITDA of $60,000Appointment of Rob Brainin as Chief Executive Officer to lead the next phase of growthRob Brainin, newly appointed CEO of Champions, commented, "It is great to be...

Read more